337 GENES FOUND

? »

Limit search: Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

« prev | Page of 7 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SLC26A1Solute carrier family 26 (anion exchanger), member 1Plasma proteins
Predicted membrane proteins
Transporters
Tissue enhanced
SLC26A10Solute carrier family 26, member 10Predicted membrane proteins
Transporters
Not detected
SLC26A11Solute carrier family 26 (anion exchanger), member 11Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
SLC26A2Solute carrier family 26 (anion exchanger), member 2Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Group enriched
SLC26A3Solute carrier family 26 (anion exchanger), member 3Cancer-related genes
Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Group enriched
SLC26A4Solute carrier family 26 (anion exchanger), member 4Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC26A6Solute carrier family 26 (anion exchanger), member 6Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
SLC26A8Solute carrier family 26 (anion exchanger), member 8Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enriched
SLC26A9Solute carrier family 26 (anion exchanger), member 9Predicted membrane proteins
Transporters
Tissue enhanced
SLC28A1Solute carrier family 28 (concentrative nucleoside transporter), member 1Predicted membrane proteins
Transporters
Group enriched
SLC28A2Solute carrier family 28 (concentrative nucleoside transporter), member 2Predicted membrane proteins
Transporters
Tissue enhanced
SLC28A3Solute carrier family 28 (concentrative nucleoside transporter), member 3Predicted membrane proteins
Transporters
Tissue enhanced
SLC29A1Solute carrier family 29 (equilibrative nucleoside transporter), member 1Predicted membrane proteins
Transporters
Expressed in all
SLC29A2Solute carrier family 29 (equilibrative nucleoside transporter), member 2Predicted membrane proteins
Transporters
Tissue enriched
SLC29A3Solute carrier family 29 (equilibrative nucleoside transporter), member 3Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Mixed
SLC29A4Solute carrier family 29 (equilibrative nucleoside transporter), member 4Predicted membrane proteins
Transporters
Tissue enriched
SLC2A1Solute carrier family 2 (facilitated glucose transporter), member 1Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
SLC2A10Solute carrier family 2 (facilitated glucose transporter), member 10Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Mixed
SLC2A11Solute carrier family 2 (facilitated glucose transporter), member 11Predicted membrane proteins
Transporters
Expressed in all
SLC2A12Solute carrier family 2 (facilitated glucose transporter), member 12Predicted membrane proteins
Transporters
Tissue enhanced
SLC2A13Solute carrier family 2 (facilitated glucose transporter), member 13Predicted membrane proteins
Transporters
Tissue enhanced
SLC2A14Solute carrier family 2 (facilitated glucose transporter), member 14Predicted intracellular proteins
Predicted membrane proteins
Transporters
Group enriched
SLC2A2Solute carrier family 2 (facilitated glucose transporter), member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC2A3Solute carrier family 2 (facilitated glucose transporter), member 3Predicted membrane proteins
Transporters
Tissue enhanced
SLC2A4Solute carrier family 2 (facilitated glucose transporter), member 4Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
SLC2A6Solute carrier family 2 (facilitated glucose transporter), member 6Predicted membrane proteins
Transporters
Mixed
SLC2A7Solute carrier family 2 (facilitated glucose transporter), member 7Predicted membrane proteins
Transporters
Group enriched
SLC2A8Solute carrier family 2 (facilitated glucose transporter), member 8Predicted membrane proteins
Transporters
Expressed in all
SLC2A9Solute carrier family 2 (facilitated glucose transporter), member 9Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
SLC30A1Solute carrier family 30 (zinc transporter), member 1Predicted membrane proteins
Transporters
Expressed in all
SLC30A10Solute carrier family 30, member 10Predicted membrane proteins
Transporters
Tissue enhanced
SLC30A2Solute carrier family 30 (zinc transporter), member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
SLC30A3Solute carrier family 30 (zinc transporter), member 3Predicted membrane proteins
Transporters
Group enriched
SLC30A4Solute carrier family 30 (zinc transporter), member 4Plasma proteins
Predicted membrane proteins
Transporters
Tissue enriched
SLC30A5Solute carrier family 30 (zinc transporter), member 5Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
SLC30A6Solute carrier family 30 (zinc transporter), member 6Predicted membrane proteins
Transporters
Expressed in all
SLC30A7Solute carrier family 30 (zinc transporter), member 7Predicted intracellular proteins
Predicted membrane proteins
Transporters
Mixed
SLC30A9Solute carrier family 30 (zinc transporter), member 9Cytoskeleton related proteins
Predicted membrane proteins
Transporters
Expressed in all
SLC32A1Solute carrier family 32 (GABA vesicular transporter), member 1Predicted membrane proteins
Transporters
Tissue enriched
SLC33A1Solute carrier family 33 (acetyl-CoA transporter), member 1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Expressed in all
SLC34A1Solute carrier family 34 (type II sodium/phosphate contransporter), member 1Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enriched
SLC34A2Solute carrier family 34 (type II sodium/phosphate contransporter), member 2Cancer-related genes
Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC34A3Solute carrier family 34 (type II sodium/phosphate contransporter), member 3Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Group enriched
SLC35A2Solute carrier family 35 (UDP-galactose transporter), member A2Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Expressed in all
SLC35A3Solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Expressed in all
SLC35A4Solute carrier family 35, member A4Predicted membrane proteins
Transporters
Expressed in all
SLC35A5Solute carrier family 35, member A5Predicted membrane proteins
Transporters
Expressed in all
SLC35B1Solute carrier family 35, member B1Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
SLC35B2Solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B2Predicted membrane proteins
Transporters
Expressed in all
SLC35B3Solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B3Predicted membrane proteins
Transporters
Expressed in all

« prev | Page of 7 | next »